S. 4189
March 25, 2026
Mrs. Shaheen (for herself, Ms. Collins, Mr. Warnock, Mr. Kennedy, Ms. Rosen, Mr. Tuberville, Mr. King, Ms. Murkowski, Mr. Kelly, Mr. Grassley, Ms. Baldwin, and Mrs. Britt) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
1. Short title; table of contents; 2. Sense of Congress; TITLE I—COMMERCIAL MARKET PATIENT PROTECTIONS; 101. Requirements with respect to cost-sharing for certain insulin products; 102. Application to retiree and certain small group plans; 103. Administration; TITLE II—PHARMACY BENEFIT MANAGER TRANSPARENCY AND REBATE REFORM; 201. Full rebate on insulin pass-through to plan; TITLE III—BIOSIMILAR BIOLOGICAL PRODUCT AND GENERIC DRUG COMPETITION AND AFFORDABILITY; 301. Ensuring timely access to generics; 302. Expediting competitive biosimilar competition; 303. Insulin competition report; TITLE IV—PROGRAMS FOR PROVIDING AFFORDABLE INSULIN TO UNINSURED INDIVIDUALS; 401. Pilot program for providing affordable insulin to uninsured individuals; 402. GAO study on uninsured individuals who use insulin; 403. Insulin resource center and hotline for uninsured individuals
Pilot program for providing affordable insulin to uninsured individuals
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,